Pivot Pharmaceuticals

Pivot Pharmaceuticals Pivot is a dynamic, highly energized biopharmaceutical company with an exciting vision and future located in Boston, Massachusetts.

Pivot Pharma enters into binding Letter of Intent to acquire a controlling interest in iAmHealth CBD UG, an online nutra...
09/05/2019

Pivot Pharma enters into binding Letter of Intent to acquire a controlling interest in iAmHealth CBD UG, an online nutraceutical sales platform serving Europe.

VANCOUVER, Sept. 5, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) is pleased to announce that it has entered into a...

New CEO at Pivot Pharma
08/19/2019

New CEO at Pivot Pharma

Pivot Pharmaceuticals (OTCQB:PVOTF) has appointed Toni Rinow as Chief Executive Officer (CEO) and Dr. Renz as Regional Manager Europe in addition to serving as its Chief Medical Officer. Dr.

Pivot Pharma Begins Production of 100,000 Units of CBD Solution for Sale in the EU Market
05/21/2019

Pivot Pharma Begins Production of 100,000 Units of CBD Solution for Sale in the EU Market

VANCOUVER, May 21, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has ...

Pivot Pharma Signs Letter of Intent with Pharmascience Inc.
04/03/2019

Pivot Pharma Signs Letter of Intent with Pharmascience Inc.

VANCOUVER, April 3, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce...

Pivot Pharma Selects Shopify to Power Cannabis Product Sales in Canada
04/01/2019

Pivot Pharma Selects Shopify to Power Cannabis Product Sales in Canada

VANCOUVER, April 1, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that it has signed an...

Pivot Signs Exclusive Manufacturing Agreement with US-based Contract Manufacturer
03/28/2019

Pivot Signs Exclusive Manufacturing Agreement with US-based Contract Manufacturer

Hemp-derived CBD Capsules, Tablets, Topical Creams and Roll-on Gels to Enter US Market VANCOUVER, March 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT) ...

Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility
03/07/2019

Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility

Appoints MNP LLP As Auditor VANCOUVER, March 7, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is...

Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC
02/15/2019

Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC

Formulated Using Pivot's Thrudermicâ„¢ Transdermal Nanotechnology VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA:...

Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.
01/28/2019

Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.

Patented Topical Gels, Creams and Beverages to be Manufactured for California Market VANCOUVER, Jan. 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT /...

Pivot Secures Supply of Pharmaceutical Grade CBD Isolate from PURE Holding AG
12/20/2018

Pivot Secures Supply of Pharmaceutical Grade CBD Isolate from PURE Holding AG

Pivot Announces Completion of Definitive Agreement with Cartagena Inc.
12/18/2018

Pivot Announces Completion of Definitive Agreement with Cartagena Inc.

Address

1275 West 6th Avenue
Vancouver, BC
V6H1A6

Alerts

Be the first to know and let us send you an email when Pivot Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share